Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Dendritic Cell Sarcoma, Interdigitating × Dasatinib × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Burkitt Lymphoma 4 Multiple Myeloma 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Philadelphia Chromosome 2 Pancreatic Neoplasms 2 Neoplasms 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Glioma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1

Interventions

glofitamab 2 zanubrutinib 1 venetoclax 1 pirtobrutinib 1 pembrolizumab 1 obinutuzumab 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡